State Street’s Telesis Bio, Inc. Common Stock TBIO Stock Holding History

State Street’s Portfolio TBIO Stock Details TBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,211	Closed	-$9.59K	–	4410
2024 Q1	$9.59K	Hold	1,211	–	–	﹤0.01%	4328
2023 Q4	$8.7K	Hold	1,211	–	–	﹤0.01%	4404
2023 Q3	$22.7K	Hold	1,211	–	–	﹤0.01%	4429
2023 Q2	$34.4K	Hold	1,211	–	–	﹤0.01%	4512
2023 Q1	$67.6K	Hold	1,211	–	–	﹤0.01%	4428
2022 Q4	$27.3K	Hold	1,211	–	–	﹤0.01%	4682
2022 Q3	$36K	Sell	1,211 -910	-43%	-$32K	﹤0.01%	4728
2022 Q2	$69K	Sell	2,121 -8,745	-80%	-$604K	﹤0.01%	4657
2022 Q1	$1.05M	Buy	10,866 +2,715	+33%	+$412K	﹤0.01%	3796
2021 Q4	$1.58M	Buy	8,151 +4,172	+105%	+$649K	﹤0.01%	3710
2021 Q3	$797K	Buy	+3,979	New	+$1.01M	﹤0.01%	3833

Other funds holding TBIO

Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

DWS

Dynamic Wealth Strategies Granite Bay, California $188M AUM 12.25% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

State Street's TBIO Position: Q2 2024 in Review

State Street sold out of Telesis Bio, Inc. Common Stock (TBIO) in Q2 2024, closing a stake of 1,211 shares — an estimated $9.59K sold.

State Street first reported a position in TBIO in Q3 2021 and held it in 11 quarters. The position peaked at $1.58M in Q4 2021. 10 funds tracked by Wall St. Rank hold TBIO as of Q2 2024.

State Street reported no remaining Telesis Bio, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
State Street sold 1,211 Telesis Bio, Inc. Common Stock shares in Q2 2024, an estimated $9.59K.
State Street first reported a position in Telesis Bio, Inc. Common Stock in Q3 2021 and held it in 11 quarters.
State Street's Telesis Bio, Inc. Common Stock position peaked at $1.58M in Q4 2021.
10 funds tracked by Wall St. Rank held Telesis Bio, Inc. Common Stock as of Q2 2024.

Based on State Street's 13F filing for Q2 2024, filed 14 Aug 2024.